Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Protection Quest Is a Primary Key to Sharing the Neutralizing Antibody Response to Cover Against All Emerging Vocs Based on Biv1-Coviran Studies Publisher



Shafaati M1 ; Bagherzadeh K2, 3 ; Lotfinia M4 ; Karimi H5 ; Teimoori A6 ; Razazian M7, 8 ; Meidaninikjeh S9 ; Hosseini H10 ; Jamshidi HR11 ; Jalili H12 ; Abdoli A5, 13
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, Faculty Science, Jahrom Branch, Islamic Azad University, Jahrom, Iran
  2. 2. Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran
  5. 5. Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
  6. 6. Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  7. 7. Universite Paris Saclay, INSERM U1193, AP-HP, Hopital Paul Brousse, Virology Department, France
  8. 8. Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, Altenberger Strasse 69, Linz, 4040, Austria
  9. 9. Department of Microbiology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran
  10. 10. Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
  11. 11. Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  12. 12. Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran
  13. 13. Amirabad Virology Laboratory, Vaccine Unit, Tehran, Iran

Source: Heliyon Published:2023


Abstract

Over time, the antigenic evolution of emerging variants of SARS-CoV-2 has demanded the development of potential protective vaccines. Administration of additional doses of current vaccines based on the WT spike protein may boost immunity, but their effectiveness has dwindled for patients with more recent variants. Here, we studied the neutralization activity of post-WT strain-based vaccination and a structural simulation in-silico based on the interactions of the RBD-hACE2 as the key to initiating infection among the VOCs of SARS-CoV-2. Our data display shows that WT sera showed a markedly greater reduction in Delta and Omicron, suggesting that the Wuhan-based vaccines may be more susceptible to breakthrough and new VOCs. According to the MD simulation, mutations of Omicron result in a significant change in the variant charge distribution throughout the binding interface that consequently alters the critical interface electrostatic potential in comparison to other variants. This observation provides new insights into immunization policy and next-generation vaccine development. © 2023